Here's what Big Pharma could buy in 2025, from obesity drugs to precision cancer treatments, according to a top M&A banker
Jefferies investment banker Chris Roop discussed the Big Pharma M&A outlook with Business Insider. Check out the types of ...
FierceBiotech4d
Big Pharma layoff rounds jump 281% in '24, but overall industry rates similar to '23
Overall, biopharma layoffs rose ever so slightly in 2024 compared to the year before, though the number of layoff rounds ...
Barron's9mon
Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake.
Pfizer’s patent expirations are great for humanity but terrible for investors. The same can be said for Johnson & Johnson, Merck, and Bristol Myers.
Yahoo Finance18d
Harvest Declares Big Pharma Split Corp. December 2024 Distributions
OAKVILLE, Ontario, December 20, 2024--(BUSINESS WIRE)--Harvest Portfolios Group Inc. ("Harvest") declares the monthly cash distribution payable for Big Pharma Split Corp. of $0.1031 for each class ...